Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo

Molecular Nutrition and Food Research

Volumn 53, Issue 7, 2009, Pages 869-877

  Matsunaga, Nozomu ^a   Imai, Shunsuke ^a   Inokuchi, Yuta ^a   Shimazawa, Masamitsu ^a   Yokota, Shigeru ^b   Araki, Yoko ^c   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Wakasa Seikatsu Co Ltd   (Japan)

^c Api Company Ltd   (Japan)

Author keywords

Lipid peroxidation; NMDA; Oxidative stress; Retinal ganglion cell; SIN 1

Indexed keywords

3 MORPHOLINO SYDNONIMINE; 3-MORPHOLINO-SYDNONIMINE; ANTHOCYANIN; DRUG DERIVATIVE; MOLSIDOMINE; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; FOREBRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID PEROXIDATION; MALE; METABOLISM; MOUSE; RETINA GANGLION CELL; VACCINIUM MYRTILLUS;

ANIMALS; ANTHOCYANINS; APOPTOSIS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIPID PEROXIDATION; MALE; MICE; MOLSIDOMINE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; RETINAL GANGLION CELLS; VACCINIUM MYRTILLUS;

MUS; RATTUS; VACCINIUM MYRTILLUS;

EID: 68149124900     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800394     Document Type: Article

References (42)

1. Bonne, C., Muller, A., Villain, M., Free radicals in retinal ischemia. Gen. Pharmacol. 1998, 30, 275-280.
2. Dreyer, E. B., A proposed role for excitotoxicity in glaucoma. J. Glaucoma 1998, 7, 62-67.
3. Neufeld, A. H., Nitric oxide: A potential mediator of retinal ganglion cell damage in glaucoma. Surv. Ophthalmol. 1999, 43, S129-S135.
4. Levin, L. A., Clark, J. A., Johns, L. K., Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 1996, 37, 2744-2749.
5. McKinnon, S. J., Glaucoma, apoptosis, and neuroprotection. Curr. Opin. Ophthalmol. 1997, 8, 28-37.
6. Shimazawa, M., Inokuchi, Y., Ito, Y., Murata, H. et al., Involvement of ER stress in retinal cell death. Mol. Vis. 2007, 13,578-587.
7. Baj, A., Bombardelli, E., Gabetta, A., Martinelli, E. M., Qualitative and quantitative evaluation of Vaccinium myrtillus anthocyanins by high resolution gas chromatography and high performance liquid chromatography. J. Chromatogr. 1983,279,365-372.
8. Nakajima, J., Tanaka, I., Seo, S., Yamazaki, M., Saito, K., LC/PDA/ESI-MS profiling and radical scavenging activity of anthocyanins in various berries. J. Biomed. Biotechnol. 2004, 2004,241-247.
9. Zafra-Stone, S., Yasmin, T., Bagchi, M., Chatterjee, A. et al., Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res. 2007, 51, 675-683.
10. Morazzoni, P., Bombardelli, E., Vaccinium myrtillus. Fitoterapia 1996, 67, 3-29.
11. Morazzoni, P., Magistretti, M. J., Activity of Myrtocyanm, an anthocyanoside complex from Vaccinium myrtillus (VMA), on platelet aggregation and adhesiveness. Fitoterapia 1990, 61,13-21.
12. Matsunaga, N., Chikaraisi, Y., Shimazawa, M., Yokota, S., Hara, H., Vaccinium myrtillus (Bilberry) extracts reduce angiogenesis in vitro and in vivo. eCAM 2007, 20, DOI:10.1093/ecam/nem151.
13. Lietti, A., Cristoni, A., Picci, M., Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimittelforschung 1976, 26, 829-832.
14. Colantuoni, A., Bertuglia, S., Magistretti, M. J., Donato, L., Effects of Vaccinium myrtillus anthocyanosides on arterial vasomotion. Arzneimittelforschung 1991, 41, 905-909.
15. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., Lipton, S. A., Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 7162-7166.
16. Miles, A. M., Bohle, D. S., Glassbrenner, P. A., Hansert, B. et al., Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 1996, 271,40-47.
17. Radi, R., Beckman, J. S., Bush, K. M., Freeman, B. A., Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 1991, 288, 481-487.
18. Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D. et al., Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391, 393-397.
19. Eissa, L. A., Smith, S. B., El-Sherbeny, A., Regulation of taurine transporter activity in cultured rat retinal ganglion cells and rat retinal Müller cells. Saudi Pharm. J. 2006, 14, 16-26.
20. Li, Y., Schlamp, C. L., Nickells, R. W., Experimental induction of retinal ganglion cell death in adult mice. Invest. Ophthalmol. Vis. Sci. 1999, 40, 1004-1008.
21. El-Remessy, A. B., Khalil, I. E., Matragoon, S., Abou-Mohamed, G. et al., Neuroprotective effect of (-) delta9-tetra-hydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: Involvement of peroxynitrite. Am. J. Pathol. 2003, 163, 1997-2008.
22. Shimazawa, M., Yamashita, T., Afarwal, N., Hara, H., Neuro-protective effects of minocycline against in vitro and in vivo retinal cell damage. Brain Res. 2005, 1053, 185-194.
23. Tominaga, H., Ishiyama, M., Ohseto, F., Sasamoto, K. et al., A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal. Commun. 1999, 36, 47-50.
24. Nakajima, Y., Inokuchi, Y., Shimazawa, M., Otsubo, K. et al., Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in vitro and in mice in vivo. J. Pharm. Pharmacol. 2008, 60, 1365-1374.
25. Hara, H., Kogure, K., Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative). J. Pharmacol. Exp. Ther. 1990,255,906-913.
26. Yoneda, S., Tanihara, H., Kido, N., Honda, Y. et al., Interleu-kin-1beta mediates ischemic injury in the rat retina. Exp. Eye Res. 2001, 73, 661-667.
27. Talavéra, S., Felgines, C., Texier, O., Besson, C. et al., Anthocyanins are efficiently absorbed from the stomach in anesthetized rats. J. Nutr. 2003, 133, 4178-4182.
28. Vinson, J. A., Dabbagh, Y. A., Serry, M. M., Jang, J., Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J. Agric. Food Chem. 1995, 43, 2800-2802.
29. Torel, J., Cillard, J., Cillard, P., Antioxidant activity of flavor-noids and reactivity with peroxy radical. Phytochemistry 1986,25,383-385.
30. Rossetto, M., Vanzani, P., Mattivi, F., Lunelli, M. et al., Synergistic antioxidant effect of catechin and malvidin 3-gluco-side on free radical-initiated peroxidation of linoleic acid in micelles. Arch. Biochem. Biophys. 2002, 408, 239-245.
31. Tamura, H., Yamagami, A., Antioxidative activity of mono-acylated anthocyanins isolated from Muscat Bailey a grape. J. Agric. Food Chem. 1994, 42, 1612-1615.
32. Bao, L., Yao, X. S., Yau, C. C., Tsi, D. et al., Protective effects of bilberry (Vaccinium myrtillus L.) extract on restraint stress-induced liver damage in mice. J. Agric. Food. Chem. 2008,56,7803-7807.
33. Morazzoni, P., Livio, S., Scilingo, A., Malandrino, S., Vaccinium myrtillus anthocyanosides pharmacokinetics in rats. Arzneimittelforschung 1991, 41, 128-131.
34. Trackey, J. L., Uliasz, T. F., Hewett, S. J., SIN-1-induced cyto-toxicity in mixed cortical cell culture: Peroxynitrite-dependent and -independent induction of excitotoxic cell death. J. Neurochem. 2001, 79, 445-455.
35. Feelisch, M., The biochemical pathways of nitric oxide formation from nitrovasodilators: Appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 1991, 17, S25-S33.
36. Holm, P., Kankaanranta, H., Metsa-Ketela, T., Moilanen, E., Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur. J. Pharmacol. 1998, 346, 97-102.
37. Darley-Usmar, V. M., Hogg, N., O'Leary, V. J., Wilson, M. T., Moncada, S., The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 1992, 17, 9-20.
38. Lipton, S. A., Rosenberg, P. A., Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 1994, 330, 613-622.
39. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., Snyder, S. H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 1991,88,6368-6371.
40. Lafon-Cazal, M., Pietri, S., Culcasi, M., Bockaert, J., NMDA-dependent superoxide production and neurotoxicity. Nature 1993, 364, 535-537.
41. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., Freeman, B. A., Apparent hydroxyl radical production by per-oxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 1990, 87,1620-1624.
42. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z. et al., A redox-based mechanism for the neuroprotective and neuro-destructive effects of nitric oxide and related nitroso-com-pounds. Nature 1993, 364, 626-632.